Caesarean section and neonatal physiology

C-section anaesthesia balances the mother’s anaesthesia and analgesia with neonatal drug exposure. My note and the book say only xylazine adversely affects survival. The cited canine study also associated methoxyflurane with poorer litter survival. This was observational; it does not prove every other drug is safe.

The book lists propofol OR alfaxalone with a benzodiazepine, or ketamine with a benzodiazepine, as maternal induction options. Neonatal depression depends on the regimen. Maternal benzodiazepines can depress newborn breathing.

Epidural lidocaine provides analgesia before incision. Added morphine provides neuraxial analgesia for the mother after surgery and may reduce systemic opioid use.

My inhalant cue is “a couple of breaths”. Effective ventilation is needed; two breaths do not guarantee complete washout or recovery. A weak or apnoeic newborn needs assessment and respiratory support. RECOVER 2025 recommends appropriate reversal when resuscitation is needed after maternal opioids, α2 agonists or benzodiazepines. For vigorous exposed newborns, evidence is insufficient for or against routine reversal.

The first-2-month study cue links cardiac output to heart rate because stroke volume has limited room to increase. Heart rate is not its only determinant. Liver function and renal concentrating ability are immature, so the note cautions against drugs needing extensive hepatic metabolism or renal excretion. Maturation and drug handling vary; 2 months is not a universal cutoff.

The bottom sequence is a separate neonatal example: full or partial opioid agonist + midazolam → propofol → isoflurane. Opioids and inhalants can depress breathing. Close monitoring and preparation for intubation belong with that example.

References

Johnston & Tobias, 2nd ed., Ch22; Moon et al. 2000; Luna et al. 2004; RECOVER 2025.